WASHINGTON, June 25 -- National Institutes of Health has issued a notice called: Government Owned Inventions Available for License: C8166-45 Cell Line.

The notice was published in the Federal Register on June 25 by Richard U. Rodriguez, Associate Director, Technology Transfer Center, National Cancer Institute.

Summary: The National Cancer Institute (NCI) seeks licensees for a human T-cell line, C8166-45, transformed by HTLV-1. C8166-45, also known as C63/CRII-2, contains three transcriptionally active proviruses useful for testing biological activities involved in T-cell immortalization and growth.

For more information, contact Inquiries related to this license opportunity should be directed to: Diptadip Dattaroy, Ph.D, Technology Transf...